Emma D. Johnson

Dundee, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Endotypes of Pseudomonas aeruginosa Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4).

Endotypes of Pseudomonas aeruginosa Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4).

Journal: American journal of respiratory and critical care medicine
Published: July 15, 2025

Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study.

Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study.

Journal: The Lancet. Respiratory medicine
Published: March 11, 2025

Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial.

Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial.

Journal: American journal of respiratory and critical care medicine
Published: February 12, 2025

Dipeptidyl peptidase-1 inhibitors in bronchiectasis.

Dipeptidyl peptidase-1 inhibitors in bronchiectasis.

Journal: European respiratory review : an official journal of the European Respiratory Society
Published: November 21, 2024

What is the future of inhaled antibiotics for bronchiectasis?

What is the future of inhaled antibiotics for bronchiectasis?

Journal: Expert review of respiratory medicine
Published: November 04, 2024

Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study.

Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study.

Journal: The Lancet. Respiratory medicine
Published: October 16, 2024

Exacerbations of bronchiectasis.

Exacerbations of bronchiectasis.

Journal: European respiratory review : an official journal of the European Respiratory Society
Published: April 18, 2024

Optimising antibiotic treatment duration in ventilator-associated pneumonia.

Optimising antibiotic treatment duration in ventilator-associated pneumonia.

Journal: The Lancet. Respiratory medicine
Published: December 19, 2023

Biomarkers in bronchiectasis.

Biomarkers in bronchiectasis.

Journal: European respiratory review : an official journal of the European Respiratory Society
Published: November 13, 2023

Impact of epilepsy on learning and behaviour and needed supports: Views of children, parents and school staff.

Impact of epilepsy on learning and behaviour and needed supports: Views of children, parents and school staff.

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: January 18, 2022

Inclusion and participation of children with epilepsy in schools: Views of young people, school staff and parents.

Inclusion and participation of children with epilepsy in schools: Views of young people, school staff and parents.

Journal: Seizure
Published: July 11, 2021

Is an opt-out system likely to increase organ donation?

Is an opt-out system likely to increase organ donation?

Journal: BMJ (Clinical research ed.)
Published: March 08, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026